IE Smith

587 total citations
18 papers, 463 citations indexed

About

IE Smith is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, IE Smith has authored 18 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in IE Smith's work include Estrogen and related hormone effects (5 papers), Lung Cancer Research Studies (3 papers) and Breast Cancer Treatment Studies (3 papers). IE Smith is often cited by papers focused on Estrogen and related hormone effects (5 papers), Lung Cancer Research Studies (3 papers) and Breast Cancer Treatment Studies (3 papers). IE Smith collaborates with scholars based in United Kingdom, Switzerland and United States. IE Smith's co-authors include Mitch Dowsett, K. Priest, MC Nicolson, S.E. Ashley, J M Shneerson, Michael Jarman, J D Teale, J.C. Reubi, Jeremy Millar and S. Johnston and has published in prestigious journals such as The Lancet, Cancer Research and British Journal of Cancer.

In The Last Decade

IE Smith

17 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
IE Smith United Kingdom 10 237 185 128 114 68 18 463
P J Johnson United Kingdom 11 228 1.0× 116 0.6× 96 0.8× 107 0.9× 183 2.7× 16 626
Leonard Sadoff United States 12 188 0.8× 52 0.3× 54 0.4× 95 0.8× 114 1.7× 27 439
Christina Wei United States 8 178 0.8× 106 0.6× 95 0.7× 79 0.7× 56 0.8× 26 411
Iwao Ono Japan 8 164 0.7× 179 1.0× 118 0.9× 119 1.0× 38 0.6× 18 425
P Rudziński Poland 10 111 0.5× 101 0.5× 24 0.2× 115 1.0× 46 0.7× 28 383
Yuzo Minami Japan 11 123 0.5× 129 0.7× 30 0.2× 81 0.7× 62 0.9× 35 373
Mary Ann Johnston United States 9 136 0.6× 136 0.7× 89 0.7× 214 1.9× 20 0.3× 19 631
María Santos Spain 11 113 0.5× 103 0.6× 70 0.5× 219 1.9× 21 0.3× 20 500
Kathrin Strasser Austria 9 145 0.6× 55 0.3× 215 1.7× 84 0.7× 12 0.2× 16 415
G Concolino Italy 12 55 0.2× 111 0.6× 106 0.8× 114 1.0× 38 0.6× 30 334

Countries citing papers authored by IE Smith

Since Specialization
Citations

This map shows the geographic impact of IE Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by IE Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites IE Smith more than expected).

Fields of papers citing papers by IE Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by IE Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by IE Smith. The network helps show where IE Smith may publish in the future.

Co-authorship network of co-authors of IE Smith

This figure shows the co-authorship network connecting the top 25 collaborators of IE Smith. A scholar is included among the top collaborators of IE Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with IE Smith. IE Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Bennett, Maxine, Jake Jordan, Nicholas Oscroft, et al.. (2013). S1 TOMADO: A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea. Thorax. 68(Suppl 3). A4.1–A4. 1 indexed citations
3.
Bliss, Judith M., Lucy Kilburn, IE Smith, et al.. (2011). OT2-03-04: A Trial Model for the Future in the Search for Personalised Medicine – The UK POETIC and EPHOS-B Perioperative Trials Experience.. Cancer Research. 71(24_Supplement). OT2–3. 1 indexed citations
4.
Gevensleben, Heidrun, et al.. (2011). PD05-06: Determination of HER2 Status with Analysis of Plasma DNA by Digital PCR in Patients with Metastatic Breast Cancer.. Cancer Research. 71(24_Supplement). PD05–6. 1 indexed citations
5.
6.
Smith, IE, Mitch Dowsett, P Trunet, et al.. (1996). Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer. British Journal of Cancer. 73(4). 539–542. 23 indexed citations
7.
Smith, IE & J M Shneerson. (1996). A laboratory comparison of four positive pressure ventilators used in the home. European Respiratory Journal. 9(11). 2410–2415. 27 indexed citations
8.
Bonnefoi, Hervé & IE Smith. (1996). How should cancer presenting as a malignant pleural effusion be managed?. British Journal of Cancer. 74(5). 832–835. 17 indexed citations
9.
Ellis, PA, et al.. (1995). A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer. British Journal of Cancer. 71(6). 1315–1318. 2 indexed citations
10.
Smith, IE, et al.. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. British Journal of Cancer. 71(2). 366–370. 144 indexed citations
11.
Johnston, S., Mitch Dowsett, IE Smith, et al.. (1993). Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. The Lancet. 342(8886-8887). 1521–1522. 65 indexed citations
12.
Johnston, S., Janine Salter, KA MacLennan, et al.. (1992). Short term tamoxifen induces the cytoplasmic expression of c-erbB2 and BCL-2 in er-positive human primary breast cancer. The Breast. 1(3). 166–166. 6 indexed citations
13.
Smith, IE, et al.. (1991). Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer. British Journal of Cancer. 64(3). 451–456. 69 indexed citations
14.
Mansi, J, DR Newell, J. Glaholm, et al.. (1991). A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer. British Journal of Cancer. 64(3). 593–597. 32 indexed citations
15.
Dowsett, Mitch, et al.. (1989). Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects. British Journal of Cancer. 60(4). 644–648. 21 indexed citations
16.
Macaulay, Valentine M., et al.. (1987). A high molecular weight non-bombesin/gastrin releasing peptide growth factor in small cell lung cancer. British Journal of Cancer. 56(6). 791–794. 3 indexed citations
17.
Dowsett, Mitch, et al.. (1987). The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. British Journal of Cancer. 55(3). 311–313. 21 indexed citations
18.
Robinson, Bonnie, et al.. (1984). PHASE-I CLINICAL-TRIAL OF CB3717 ((N-(4-(N-((2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID). Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P J Johnson Breakdown of academic impact, for papers by Leonard Sadoff Breakdown of academic impact, for papers by Christina Wei Breakdown of academic impact, for papers by Iwao Ono Breakdown of academic impact, for papers by P Rudziński Breakdown of academic impact, for papers by Yuzo Minami Breakdown of academic impact, for papers by Mary Ann Johnston Breakdown of academic impact, for papers by María Santos Breakdown of academic impact, for papers by Kathrin Strasser Breakdown of academic impact, for papers by G Concolino
Rankless by CCL
2026